Article
Drugmaker Novo Nordisk seeks obesity, diabetes 'bolt-on' deals
Rating:
0.0
Views:
41
Likes:
1
Library:
1
Novo Nordisk wants to buy more companies with drugs in early- to mid-stages of development through "bolt-on" deals of up to a few billion dollars, CEO Lars Fruergaard Jorgensen told Reuters on Friday.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value